Donepezil transdermal patch price and purchase channels
The price of donepezil transdermal patch varies by region, provider and health insurance coverage. In the U.S. market, the drug is usually sold in boxes of 4 tablets, equivalent to one month's supply.
In American pharmacies or online pharmacies, the price of Adlarity is usually 500-700USD/ box, equivalent to about 3500-5000 yuan in RMB. Prices may be reduced if the patient has commercial health insurance or is eligible for a government health insurance plan (e.g., Medicare, Medicaid). In Japan, the price of donepezil transdermal patches varies due to different medical insurance reimbursements. For specific prices, please consult local pharmacies or hospitals.
For domestic patients, since the drug has not yet been launched in China, the main ways to obtain it include the following:
Overseas medical institutions: Some international hospitals or overseas medical institutions may provide remote diagnosis and treatment and drug purchasing services. Patients can purchase drugs abroad with a doctor's prescription and have them delivered by international express delivery.
Cross-border e-commerce: Some cross-border drug purchasing platforms may provide legally imported donepezil transdermal patches, but you need to pay attention to choosing a regular platform to avoid purchasing counterfeit drugs.
Overseas purchasing agents: Some purchasing agents can purchase drugs from countries such as the United States and Japan and transport them to China. However, such channels have certain risks and may involve problems such as unknown sources of drugs and restricted transportation. Therefore, patients should choose carefully.
Purchasing drugs overseas: Some patients or family members may choose to purchase directly from hospitals or pharmacies in countries such as the United States and Japan, but they need to follow the drug purchase regulations of the relevant countries and ensure that they have a doctor's prescription.
No matter how you purchase it, patients should use it under the guidance of a doctor and follow up regularly to ensure the safety and effectiveness of the medication.
References: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212304s000lbl.pdf
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)